Acute Investment Advisory’s Goldman Sachs Access Treasury 0-1 Year ETF GBIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,262
Closed -$326K 18
2024
Q4
$326K Sell
3,262
-178,630
-98% -$17.9M 0.36% 16
2024
Q3
$18.2M Sell
181,892
-3,178
-2% -$318K 10.48% 4
2024
Q2
$18.5M Sell
185,070
-996
-0.5% -$99.5K 10.56% 4
2024
Q1
$18.8M Buy
186,066
+7,910
+4% +$791K 12.59% 3
2023
Q4
$17.8M Buy
178,156
+8,935
+5% +$893K 10.51% 3
2023
Q3
$16.9M Buy
+169,221
New +$16.9M 10.18% 3

Other funds holding GBIL

Acute Investment Advisory's GBIL Position: Q1 2025 in Review

Acute Investment Advisory sold out of Goldman Sachs Access Treasury 0-1 Year ETF (GBIL) in Q1 2025, closing a stake of 3,262 shares — an estimated $326K sold.

Acute Investment Advisory first reported a position in GBIL in Q3 2023 and held it in 6 quarters. The position peaked at $18.8M in Q1 2024. 342 funds tracked by Wall St. Rank hold GBIL as of Q1 2025.

  • Acute Investment Advisory reported no remaining Goldman Sachs Access Treasury 0-1 Year ETF position as of Q1 2025 after selling out during the quarter.
  • Acute Investment Advisory sold 3,262 Goldman Sachs Access Treasury 0-1 Year ETF shares in Q1 2025, an estimated $326K.
  • Acute Investment Advisory first reported a position in Goldman Sachs Access Treasury 0-1 Year ETF in Q3 2023 and held it in 6 quarters.
  • Acute Investment Advisory's Goldman Sachs Access Treasury 0-1 Year ETF position peaked at $18.8M in Q1 2024.
  • 342 funds tracked by Wall St. Rank held Goldman Sachs Access Treasury 0-1 Year ETF as of Q1 2025.

Based on Acute Investment Advisory's 13F filing for Q1 2025, filed 28 Apr 2025.